TransCode Therapeutics - SEC Filing
Por um escritor misterioso
Descrição
TriSalus Life Sciences Appoints James
TransCode Therapeutics - SEC Filing
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics Announces Public Offering of Common Stock
Cutera Cancels Special Meeting
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics Manhattan Street Capital
S-1
tm2038085-5_s1 - none - 15.3906315s
TransCode Therapeutics Announces Public Offering of Common Stock
de
por adulto (o preço varia de acordo com o tamanho do grupo)
